Biotricity, Inc.
BTCY
$0.11
$0.00-2.47%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.25% | 41.66% | 55.76% | 81.81% | 53.72% |
| Total Depreciation and Amortization | 13.69% | 13.57% | 13.56% | 0.00% | -70.39% |
| Total Amortization of Deferred Charges | 24.74% | -36.28% | -40.54% | -86.58% | -72.49% |
| Total Other Non-Cash Items | -99.63% | 163.06% | -34.78% | -85.18% | 7,820.00% |
| Change in Net Operating Assets | 94.30% | -176.98% | 11.09% | -93.46% | -127.57% |
| Cash from Operations | 94.79% | -740.30% | 204.66% | 75.01% | 65.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -132.69% | 12.77% | -52.23% | -- | -42.43% |
| Total Debt Repaid | 123.62% | 72.73% | -5.73% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.64% | -1.69% | -1.67% | 50.83% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -155.45% | 69.72% | -207.77% | -49.82% | -90.77% |
| Foreign Exchange rate Adjustments | -97.59% | 78.56% | 720.00% | 38.95% | 213.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.23% | -115.49% | -214.21% | 103.81% | -120.61% |